Balyasny Asset Management’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.18M Buy
+50,000
New +$5.67M 0.01% 1347
2025
Q3
Sell
-3,500
Closed -$420K 2980
2025
Q2
$420K Sell
3,500
-28,700
-89% -$3.83M ﹤0.01% 2356
2025
Q1
$4.74M Buy
+32,200
New +$4.92M 0.01% 1273
2024
Q4
Sell
-19,700
Closed -$3.21M 2809
2024
Q3
$3.21M Buy
+19,700
New +$2.92M 0.01% 1462
2022
Q4
Sell
-10,000
Closed -$1.28M 2827
2022
Q3
$1.28M Buy
+10,000
New +$1.44M ﹤0.01% 1698
2020
Q4
Sell
-30,000
Closed -$6.3M 1367
2020
Q3
$6.3M Buy
+30,000
New +$6.68M 0.05% 525

Other funds holding CLX

Balyasny Asset Management's CLX Position: Q1 2026 in Review

Balyasny Asset Management reduced its Clorox (CLX) stake by 4.2% in Q1 2026, selling an estimated $819K and leaving 163,733 shares worth $17M. The position accounts for 0.02% of the portfolio, ranked #756.

Balyasny Asset Management first reported a position in CLX in Q4 2015 and has held it in 28 quarters since. The position peaked at $231M in Q4 2024. 1,080 funds tracked by Wall St. Rank hold CLX as of Q1 2026.

  • Balyasny Asset Management held 163,733 shares of Clorox worth $17M as of Q1 2026.
  • Balyasny Asset Management sold 7,225 Clorox shares in Q1 2026, an estimated $819K.
  • Clorox made up 0.02% of Balyasny Asset Management's portfolio in Q1 2026, its #756 holding.
  • Balyasny Asset Management first reported a position in Clorox in Q4 2015 and has held it in 28 quarters since.
  • Balyasny Asset Management's Clorox position peaked at $231M in Q4 2024.
  • 1,080 funds tracked by Wall St. Rank held Clorox as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.